IPP Bureau
3Brain AG's Accura-3D microchip, enters the market
By IPP Bureau - August 24, 2022
3D CMOS chip for connecting electroactive tissues and organoids to software
Merck gets fast track designation from the USFDA for anticoagulant therapy
By IPP Bureau - August 24, 2022
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
Dozee and Midmark to launch India’s first intelligent connected bed with Remote Patient Monitoring and EWS
By IPP Bureau - August 24, 2022
The intelligent connected bed is one of the most significant breakthroughs in India’s journey to create a world-class connected healthcare system to deliver quality healthcare to a billion Indians.
Nursing and Midwifery associations call out the urgent need for policy support to drive a robust health workforce in India
By IPP Bureau - August 24, 2022
Today, India stands at 1.7 nurses per 1,000 population, as opposed to the World Health Organization norm of 3 nurses per 1000.
Mojocare secures US$20.6 million in Series A Funding
By IPP Bureau - August 24, 2022
The funding round also saw participation from some of India's top angel investors and leading industry giants
Lessons from COVID management valuable beacons for cancer prevention and treatment: Union Health Secretary
By IPP Bureau - August 24, 2022
The pandemic has taught us that health is not the exclusive responsibility of only the Union Health Ministry but jointly addressed by various Ministries at the centre and through state governments
Glenmark receives OAI communication from US FDA
By IPP Bureau - August 24, 2022
The company continues to cooperate with the US FDA and is committed to undertake all necessary steps required to address their observations at the earliest
Unichem Laboratories receives ANDA approval for Carbamazepine Tablets
By IPP Bureau - August 24, 2022
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
Jaslok Hospital launches coordination center in Oman
By IPP Bureau - August 24, 2022
The citizens of Oman will soon have a coordination center that will provide end to end services for healthcare facilities of Jaslok.
Eugia Pharma receives USFDA pproval for Medroxyprogesterone Acetate injectable suspension
By IPP Bureau - August 24, 2022
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
Celanese announces Grant Award to develop refillable drug delivery solution
By IPP Bureau - August 24, 2022
Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
Arsenal Capital raises $5.4 billion for two new funds
By IPP Bureau - August 23, 2022
Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
Lonza introduces X-ray powder diffraction at Monteggio
By IPP Bureau - August 23, 2022
This rapid analytical technique provides additional information about the polymorph and solid-state properties of active pharmaceutical ingredients (APIs)
Health Minister Mandaviya addresses Bharat Swaasth Mahotsav
By IPP Bureau - August 23, 2022
Bharat Swasth Mahotsav organises ‘Padma Doctors Congregation’ for Celebrating Healthcare Changemakers in India Since Independence
Dr. Jitendra Singh announces 75 Amrit Grants for biotech initiatives
By IPP Bureau - August 23, 2022
75 inter-disciplinary, multi-institutional grants would be supported for high-risk, ambitious research ideas, milestones-driven collaborative research in all domain areas of the biotech sector
